Compounds > temozolomide
Page last updated: 2024-08-16

temozolomide and lignans

temozolomide has been researched along with lignans in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chuang, SE; Hu, TS; Lai, GM; Lai, IC; Lai, TY; Lui, TN; Shih, PH; Wang-Peng, J; Yao, CJ; Yeh, CT1
Ahluwalia, MS; Barnett, GH; Chao, ST; Jia, X; Kotecha, R; Leyrer, CM; Murphy, ES; Parsons, M; Peereboom, DM; Prayson, RA; Stevens, GHJ; Suh, JH; Vogelbaum, MA; Yu, JS1
Chang, CK; Chen, KY; Chen, RM; Chio, CC; Chuang, JY; Liu, CC; Liu, SH1
Chen, RM; Chio, CC; Liu, SH; Mohanraj, M; Tai, YT; Yang, ST1
Chen, RM; Wu, GJ; Yang, ST1

Other Studies

5 other study(ies) available for temozolomide and lignans

ArticleYear
Elimination of cancer stem-like cells and potentiation of temozolomide sensitivity by Honokiol in glioblastoma multiforme cells.
    PloS one, 2015, Volume: 10, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Biphenyl Compounds; Brain Neoplasms; Cell Proliferation; Dacarbazine; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Drug Therapy, Combination; Glioblastoma; Homeodomain Proteins; Humans; Lignans; Neoplastic Stem Cells; Receptor, Notch3; Receptors, Notch; Temozolomide; Transcription Factor HES-1; Tumor Cells, Cultured

2015
Risk Factors for Malignant Transformation of Low-Grade Glioma.
    International journal of radiation oncology, biology, physics, 2018, 03-15, Volume: 100, Issue:4

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Transformation, Neoplastic; Chi-Square Distribution; Child; Child, Preschool; Female; Glioma; Glycosides; Humans; Incidence; Infant; Lignans; Male; Middle Aged; Progression-Free Survival; Risk Factors; Sex Factors; Statistics, Nonparametric; Temozolomide; Time Factors; Young Adult

2018
Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells.
    BMC cancer, 2018, 04-03, Volume: 18, Issue:1

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Biphenyl Compounds; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Glioma; Humans; Lignans; Temozolomide

2018
Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2018, Oct-01, Volume: 49

    Topics: Animals; Apoptosis; Biphenyl Compounds; Caspases; Cell Line, Tumor; Cell Survival; Cytochromes c; Dacarbazine; DNA Fragmentation; Drugs, Chinese Herbal; Fas Ligand Protein; Glioma; Humans; Lignans; Membrane Potential, Mitochondrial; Mice; Mitochondria; Reactive Oxygen Species; Signal Transduction; Temozolomide

2018
Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells.
    Molecules (Basel, Switzerland), 2020, Mar-23, Volume: 25, Issue:6

    Topics: Apoptosis; Biphenyl Compounds; Caspase 9; Cell Line, Tumor; Drug Resistance, Neoplasm; Enzyme Activation; Glioblastoma; Humans; Lignans; Mitochondria; Neoplasm Proteins; Temozolomide

2020